Heiligenhaus A - Search Results

1

Corrigendum to "Antibody-based immunotherapy of acyclovir resistant ocular herpes simplex virus infection" [Virology 512 (2017) 194-200].

Bauer D, Keller J, Alt M, Schubert A, Aufderhorst UW, Palapys V, Kasper M, Heilingloh CS, Dittmer U, Laffer B, Eis-Hübinger AM, Verjans GM, Heiligenhaus A, Roggendorf M, Krawczyk A. Bauer D, et al. Among authors: heiligenhaus a. Virology. 2019 Jan 2;526:231-232. doi: 10.1016/j.virol.2018.09.012. Epub 2018 Oct 2. Virology. 2019. PMID: 30290967 Free article. No abstract available.

2

Macrophage-depletion influences the course of murine HSV-1 keratitis.

Bauer D, Mrzyk S, van Rooijen N, Steuhl KP, Heiligenhaus A. Bauer D, et al. Among authors: heiligenhaus a. Curr Eye Res. 2000 Jan;20(1):45-53. Curr Eye Res. 2000. PMID: 10611714

3

Herpes simplex virus type 1 infection of the cornea.

Heiligenhaus A, Bauer D. Heiligenhaus A, et al. Dev Ophthalmol. 1999;30:141-66. doi: 10.1159/000060741. Dev Ophthalmol. 1999. PMID: 10627922 Review. No abstract available.

4

[Apoptosis in human non-necrotizing stromal herpes simplex keratitis].

Heiligenhaus A, Mrzyk S, Bauer D, Steuhl KP. Heiligenhaus A, et al. Klin Monbl Augenheilkd. 2000 Sep;217(3):178-82. doi: 10.1055/s-2000-10342. Klin Monbl Augenheilkd. 2000. PMID: 11076349 German.

5

Incidence and severity of herpetic stromal keratitis: impaired by the depletion of lymph node macrophages.

Bauer D, Mrzyk S, Van Rooijen N, Steuhl KP, Heiligenhaus A. Bauer D, et al. Among authors: heiligenhaus a. Exp Eye Res. 2001 Mar;72(3):261-9. doi: 10.1006/exer.2000.0947. Exp Eye Res. 2001. PMID: 11180975

6

Conjunctival macrophage-mediated influence of the local and systemic immune response after corneal herpes simplex virus-1 infection.

Bauer D, Schmitz A, Van Rooijen N, Steuhl KP, Heiligenhaus A. Bauer D, et al. Among authors: heiligenhaus a. Immunology. 2002 Sep;107(1):118-28. doi: 10.1046/j.1365-2567.2002.01477.x. Immunology. 2002. PMID: 12225370 Free PMC article.

7

[Amniotic membrane transplantation improves herpetic keratitis by local and not by systemic effects].

Heiligenhaus A, Bauer D, Wasmuth S, Steuhl KP. Heiligenhaus A, et al. Ophthalmologe. 2003 Mar;100(3):209-15. doi: 10.1007/s00347-002-0720-z. Ophthalmologe. 2003. PMID: 12640550 German.

8

Matrix metalloproteinases (MMP-2 and 9) and tissue inhibitors of matrix metalloproteinases (TIMP-1 and 2) during the course of experimental necrotizing herpetic keratitis.

Yang YN, Bauer D, Wasmuth S, Steuhl KP, Heiligenhaus A. Yang YN, et al. Among authors: heiligenhaus a. Exp Eye Res. 2003 Aug;77(2):227-37. doi: 10.1016/s0014-4835(03)00112-x. Exp Eye Res. 2003. PMID: 12873454

9

Topical treatment with antisense oligonucleotides targeting tumor necrosis factor-alpha in herpetic stromal keratitis.

Wasmuth S, Bauer D, Yang Y, Steuhl KP, Heiligenhaus A. Wasmuth S, et al. Among authors: heiligenhaus a. Invest Ophthalmol Vis Sci. 2003 Dec;44(12):5228-34. doi: 10.1167/iovs.03-0312. Invest Ophthalmol Vis Sci. 2003. PMID: 14638721

10

[Amniotic membrane transplantation improves experimental herpetic keratitis. Modulation of matrix metalloproteinase-9].

Heiligenhaus A, Li H, Yang Y, Wasmuth S, Bauer D, Steuhl KP. Heiligenhaus A, et al. Ophthalmologe. 2004 Jan;101(1):59-65. doi: 10.1007/s00347-003-0872-5. Ophthalmologe. 2004. PMID: 14872270 German.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

302 results

Search Page

Filters